Cipla Articles
Mylan delivers "one pill once a day" ARV in South Africa; Cipla Debuts first Enbrel biosimilar
17 April 2013
India's Cipla ups bid for Cipla Medpro now seeking 100% control for around $512 million
1 March 2013
Cipla prevails in Sutent patent dispute with Pfizer; puts hold on Cipla Medpro deal
12 February 2013
Impax in deal with Perrigo; Cipla eyes South Africa acquisition
22 November 2012
India's Cipla cuts prices of three cancer drugs
12 November 2012
AstraZeneca drops early-stage obesity drug; Roche loses out on Indian Tarceva dispute
10 September 2012
Speculation Takeda is looking to buy India’s Cipla or Lupin; Sanofi acquires OTC firm
25 August 2011
Lupin may invest $50 million in Russian plant; Indian drugmakers doing well with ARVs
11 February 2011
Dr Reddy’s expands portfolio in Russia and CIS via in-licensing deals with Cipla and Vitabiotics
26 October 2010
Cipla to buy fellow Indian drugmaker Meditab in $28.5 deal
27 August 2010
Showing 1-14 of 14 articles
- 1
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
